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Abstract
Traumatic brain injury (TBI) is ubiquitous and effective treatments for it remain supportive
largely due to uncertainty over how endogenous repair occurs. Recently, we demonstrated
that hippocampal injury-induced neurogenesis is one mechanism underlying endogenous
repair following TBI. Donepezil is associated with increased hippocampal neurogenesis
and has long been known to improve certain aspects of cognition following many types of
brain injury through unknown mechanisms. By coupling donepezil therapy with temporally
regulated ablation of injury-induced neurogenesis using nestin-HSV transgenic mice, we in-
vestigated whether the pro-cognitive effects of donepezil following injury might occur
through increasing neurogenesis. We demonstrate that donepezil itself enhances neuro-
genesis and improves cognitive function following TBI, even when injury-induced neurogen-
esis was inhibited. This suggests that the therapeutic effects of donepezil in TBI occur
separately from its effects on neurogenesis.
Introduction
Traumatic brain injury is a ubiquitous and devastating condition that affects millions of people
annually and can be acquired by anyone regardless of genetic background or socioeconomic
class. Despite its pervasiveness, the only known effective treatments are supportive and rely
heavily on rest and avoidance of recurrent injury. There are still no clear means of improving
outcome following traumatic brain injury, though it has been studied extensively for decades.
Part of the problem is that this kind of global injury affects many different cell types and how par-
ticular subclasses of neurons and glia respond to the same insult may be quite different. In the
last decade, injury-induced neurogenesis has fueled tremendous speculation regarding the poten-
tial of self-repair after brain injury in general and TBI in particular. After first describing the phe-
nomenon of TBI-induced neurogenesis, we subsequently demonstrated that early progenitors
become activated by injury while late-stage progenitors are vulnerable and die [1,2]. More
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recently, we have shown that genetically controlled ablation of the progenitor pool impairs func-
tional outcome after TBI, demonstrating an adaptive role for injury-induced neurogenesis [3].
In this study, we investigated if the anticholinesterase inhibitor donepezil augmented neuro-
genesis after injury to further improve recovery in cognition. Anticholinesterase inhibitors are
a mainstay of treatment for some neurodegenerative conditions such as Alzheimer disease and
have shown promise in treating those who have suffered traumatic brain injuries [4]. Donepezil
(Aricept) is the most common clinically used anticholinesterase inhibitor for both TBI and Alz-
heimer disease, though the exact mechanisms underlying cognitive enhancement are un-
known. Recent data suggest that donepezil’s pro-cognitive effects might be due to increasing
hippocampal neurogenesis [5–7].
Donepezil is an FDA-approved drug used to treat Alzheimer disease that is minimally toxic,
crosses the blood brain barrier, and specifically augments hippocampal neurogenesis. Donepe-
zil’s effects on the brain are, however, ubiquitous and it has been impossible to attribute its
pro-cognitive effects to any particular mechanism given these pleiotropic actions. Here, we ad-
ministered donepezil to nestin-HSV-TK transgenic mice, which allow for temporally regulated
ablation of neurogenesis by administration of valganciclovir to establish whether donepezil-de-
pendent hippocampal neurogenesis is beneficial following TBI. In this manner, we specifically
investigated normal injury-induced conditions, injury-induced conditions in which neurogen-
esis is inhibited, injury-induced conditions with administration of donepezil, and injury-in-
duced conditions with administration of donepezil and neurogenesis inhibited. We found that




Experimental animals were housed and cared for in the Animal Facility at Columbia University
Medical Center (CUMC), which is certified by the Association for Assessment and Accredita-
tion of Laboratory Animal Care. All animal experiments were conducted with approval of the
Institutional Animal Care and Use Committee at CUMC for the humane and compassionate
use of animals in biomedical research. We used transgenic mice, nestin-HSV-TK, which were
previously generated on a C57Bl/6 genetic background with no apparent phenotype in the ab-
sence of ganciclovir [2]. The gender and total number of nestin-HSV-TK mice used in each ex-
perimental groups were described as follows: sham mice treated with vehicle and normal chow
(5 males and 4 females), sham mice with donepezil and normal chow (6 males and 5 females),
injured mice with vehicle and normal chow (9 males and 5 females), injured mice with donepe-
zil and normal chow (6 males and 5 females), sham mice with vehicle and valganciclovir chow
(7 males and 3 females), sham mice with donepezil and valganciclovir chow (8 males and 4
females), injured mice with vehicle and valganciclovir chow (5 males and 6 females), injured
mice with donepezil and valganciclovir chow (5 males and 5 females). All animals were be-
tween 8 and 9 weeks of age when injured or mock-injured.
Controlled cortical impact injury
To perform controlled cortical impact (CCI), a standard protocol using a controlled cortical
impact device (Leica Impact One, Leica Biosystems) was used to generate brain injuries as de-
scribed previously [3]. Eight-week-old nestin-HSV-TK mice were anesthetized with isoflurane
and then placed in a stereotactic frame. A midline incision was made, the soft tissues were re-
flected, and a 5x5 mm craniotomy was made between bregma and lambda and 1 mm lateral to
the midline. The injury was generated with a 3 mm stainless steel tipped impact device with a
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deformation of 0.7 mm, constant speed of 4.4 m/s and duration of 300 milliseconds. After sur-
gery, the scalp was fastened with sutures and the mice were allowed to recover. For sham oper-
ations, mice received all the procedures noted above but the impact was not performed. After
surgery, all mice were received 5-Chloro-2-deoxyuridine (CldU) (88.5mg/Kg; Sigma) 3 days
after injury for 3 consecutive days.
Donepezil, CldU, valganciclovir administrations
Donepezil (2mg/Kg, Ivy Fine Chemicals) was injected intraperitoneally once a day for five con-
secutive days (M-F) for two weeks starting from post-operation day 3. CldU (88.5mg/Kg,
Sigma) was delivered via intraperitoneal injection once a day for 3 days following donepezil in-
jection. Valganciclovir (Valcyte, Genetech) was mixed with regular grain-based rodent diet to
produce 900mg/Kg valganciclovir chow (Custom Animal Diets, LLC, Easton, PA). Valganci-
clovir chow was provided ad libitum for ganciclovir-treated groups during the
experimental periods.
Morris water maze
The Morris water maze was conducted by an experimenter blinded to the experimental treat-
ment conditions as previously described [3]. Briefly, a white circular pool was filled with water
that was mixed with gothic white, nontoxic paint to make it opaque. A circular platform (15 cm
in diameter) was submerged 1 cm beneath the surface of the water. A number of extra-maze
cues surrounded the pool in the testing room. Training in the Morris water maze was conducted
for 11 consecutive days, and each training day consisted of 3 individual trials with an inter-trial
interval of 1 minute. During training trials, mice were allowed to swim freely until they found
the hidden platform, and if they did not find the platform in 60 seconds, they were guided to the
platform by the experimenter. For each training day, data were averaged across the three trials.
A probe trail was performed on day 12. The hidden platform was removed, and the mice were
placed in the pool and allowed to swim for 60 seconds. All data were collected using Ethovision
software (Noduls, version 9).
Immunohistochemistry
All mice were deeply anesthetized with isoflurane before perfusion. Transcardiac perfusion was
performed with phosphate-buffered saline (PBS), followed by 4% paraformaldehyde (PFA) in
1xPBS. Following post-fixation in PFA/1xPBS overnight, brains were dissected and embedded
in 3% agarose. Serial 50μm sections were cut with a vibratome (VT1000S, Leica). All sections
encompassing the hippocampus were collected sequentially in 6-well plates. Free-floating sec-
tions were used for immunohistochemistry. For CldU staining, all sections from a single well
were washed with PBS and rinsed with water. Sections were denatured with 0.1N HCl and then
washed with 0.3% Tritox X-100/1xPBS (wash buffer) 3 times and blocked with 5% normal don-
key serum (Jackson ImmunoResearch Labs) with buffer for 1 hour. 1:500 rat anti-BrdU anti-
body (OBT0030, Ab Serotec) and 1:500 mouse anti-NeuN antibody (clone A60, E0003, Fisher
Scientific) was used to label CldU overnight. The following day, sections were incubated with
Alexafluoro 594 donkey anti-mouse and Alexafluoro 647 donkey anti-rat IgG (all 1:200, Jack-
son ImmunoResearch) for 3 hours. The sections were placed on slides and coverslipped.
Quantification and microscopy
CldU-labeled cells in the dentate gyrus were counted using an unbiased stereological approach.
A one-in-six series of sections covering the entire hippocampus in its rostrocaudal extension
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was cut with a vibratome (Leica) at 50μm, immunostained, and visualized under light micros-
copy with the peroxidase/diaminobenzidine method. Cells were counted using an optical frac-
tionator and stereological image analysis software (StereoInvestigator; MicroBrightField)
operating a computer-driven microscope (Imager M2, Zeiss) regulated in the x-, y-, and z-axes.
Areas to be counted were traced with a 20x objective lens, and sample frames (70 X 70μm)
were selected at random by the image analysis software. Cells in the counting frame (40 X
40μm) were counted under a 63X oil objective lens. To avoid oversampling, the uppermost and
lowermost focal planes were excluded and the Gundersen coefficient of error was less than 0.1.
For cell quantification of NeuN/CldU-labeled cells, we used a validated method to account
for oversampling as described in detail previously [2,3,8]. A Zeiss Imager M2 microscopy was
used to determine colocalization of two immunohistochemical markers and cells were quanti-
fied with a Carl Zeiss 40X objective lens. Cell quantification was performed on the ipsilateral
and contralateral sides of the dentate gyrus in all groups. Sections were processed and collected
as above and picked randomly and stained with antibodies as free-floating sections to allow for
equal antibody penetration between sections. Sections were mounted using immunomount
(Vectashild D, Vector Labs). Antibody penetration and signal intensity were found to be evenly
distributed throughout the entire 50μm section and was verified on multiple sections from dif-
ferent animals. Each blade of the dentate gyrus was counted separately at 40X with 1.5X optical
zoom magnification. Blinded quantification was performed on cells with fully colocalized anti-
bodies in the granular layer of the dentate gyrus. Every NeuN/CldU- and CldU-labeled cell was
counted to get the percentage of total CldU-labeled cells co-labeled with NeuN (NeuN/CldU-
labeled newborn neurons) to calculate the estimated number of newborn neurons.
Feeding nestin-HSV-TK mice with valganciclovir chow resulted in ablation of the majority
of dividing neural progenitors, and rare CldU-labeled cells were observed. Therefore, we were
unable to use unbiased stereology to quantify CldU-labeled cells in valganciclovir chow-fed
nestin-HSV-TK mice. To determine whether valganciclovir was efficient in ablating dividing
neural progenitors in nestin-HSV-TK mice all CldU-labeled cells were counted. A Zeiss Imager
M2 microscopy was used to determine number of CldU-labeled cells with a Carl Zeiss 40X ob-
jective lens. Cell quantification was performed on the ipsilateral and contralateral dentate
gyrus in all groups. Sections were processed and collected as described as aboved. Each blade of
the dentate gyrus was counted separately at 40X with 1.5X optical zoom magnification. Blinded
quantification was performed on cells in the granular layer of the dentate gyrus. Every CldU-la-
beled cell was counted manually in a blinded manner and raw data without estimation or ad-
justment were presented for statistical analysis.
Statistical Analysis
Statistical analysis was performed with Prism 6 software. All behavioral data were analyzed
using two-way ANOVA with Fisher’s LSD post-hoc analysis unless otherwise specified. All
non-behavioral data were analyzed using one-way ANOVA with Fisher’s LSD post-hoc analysis
or unpaired Student’s t test.
Results
Donepezil treatment enhances neurogenesis
We first sought to determine whether donepezil enhances hippocampal neurogenesis in control
and injured animals. Mice with sham or CCI injury received one injection of donepezil (2 mg/Kg)
daily for five days (M-F) for two consecutive weeks starting three days after injury. Previous work
by us demonstrated that proliferation of neural progenitors in the injured mice peaks 3 days after
injury and donepezil has been shown inmany studies to enhance neurogenesis in mice. Therefore,
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mice received CldU (85.55 mg/Kg) once a day starting three days after surgery for 3 consecutive
days to determine if donepezil affected the peak proliferation of injury-induced neurogenesis
(Fig. 1A). Mice were sacrificed four weeks later for immunostaining to quantify numbers of
CldU-labeled cells and newborn neurons. Unbiased stereology was used to quantify numbers of
CldU-labeled cells in the dentate gyrus. Donepezil treatment resulted in a significant increase in
CldU-labeled cells in sham-operated mice but not injured mice (Fig. 1D). Moreover, the number
of newly born neurons (CldU/NeuN) was increased significantly in sham-operated mice after
donepezil treatment (Fig. 1B, C and E). In injured brains, donepezil treatment did not increase
neurogenesis on the injured side when compared with vehicle-treated controls, though it did in-
crease neurogenesis on the contralateral side of injured mice (Fig. 1E). Therefore, donepezil treat-
ment resulted in a highly significant increase of newly born neurons in sham-injured mice and on
the contralateral side of injured mice.
Donepezil treatment improved performance in spatial memory
By using CldU-labeling, we demonstrated increased numbers of neurons in the dentate gyrus
in donepezil-treated mice, in both injured and sham-injured controls. To investigate whether
Fig 1. Donepezil treatment enhanced adult neurogenesis in the dentate gyrus in sham-operated but
not injuredmice. (A) Surgery was performed on 8-week old mice (D0). Starting from D3, vehicle or
donepezil was given for 5 days a week, for 2 weeks. CldU was also injected for 3 days to label the dividing
cells. Mice were perfused for further analysis 4 weeks after surgery. (B, C) Representative pictures show that
more newly born neurons (arrows) were observed in CCI-operated mice after being treated with donepezil
when compared to control. (D) Unbiased stereology quantification revealed that donepezil treatment resulted
in a significant increase in CldU-labeled cells in the dentate gyrus in sham-operated but not injured mice. (E)
Treatment with donepezil led to a significant increase in number of newborn neurons in sham-operated mice.
One-way ANOVA with Fisher’s multiple comparisons post-hoc analysis in D and E with * p<0.05, ** p<0.01,
*** p<0.001, **** p<0.0001. Sham: sham-injured, CCI: controlled cortical injury, Veh: vehicle, Don:
donepezil, Ipsi: ipsilateral, Contra: contralateral. Number of mice used was 9 (Sham, Veh), 6 (Sham, Don) 6
(Sham, Don), 5 (CCI, Veh), 5 (CCI, Don), Scale bar in C is 50μm.
doi:10.1371/journal.pone.0118793.g001
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treatment improved learning ability and memory, the hidden platform version of the Morris
water maze was performed (Fig. 2A). Mice were trained to find the platform according to the
visible cues surrounding the water tank for 3 trials per day, on 11 consecutive days, and the
moving distance finding the platform represented their ability in learning to find the platform.
As suggested by swimming speed, the motor activity in injured mice that received no treatment
was impaired (Fig. 2B), therefore, the moving distance was used to determine the learning abili-
ty of the mice. Consistent with our previous observations, the moving distance of injured mice
without any treatment was significantly increased for finding the position of the hidden plat-
form, especially during early periods of training (Fig. 2C). Interestingly, injured mice treated
with donepezil learned to find the location of the hidden platform similar to sham-operated
mice (Fig. 2C). Therefore, donepezil treatment improved the recovery of injured mice in spatial
learning ability to that of sham-injured controls.
On day 12, the platform was removed to perform the probe test and determine if mice re-
membered the position of the platform. Time spent in the target quadrant was compared with
times in the other three quadrants to indicate how well the memory is preserved. As expected,
sham-operated mice, both with and without donepezil, spent most of the time in the target
zone. However, injured mice spent relatively less time in the target zone compared to all other
groups (Fig. 2D). Although there was no significant difference in time spent in the target quad-
rant zone between injured mice treated with vehicle or donepezil, injured mice spent more
time in the target zone in a manner similar to what was observed in controls after donepezil
treatment (Fig. 2D). Therefore, donepezil improves learning and spatial memory in mice
after injury.
Valganciclovir treatment inhibits neurogenesis in nestin-HSV-TK mice
As demonstrated in Fig. 1, donepezil treatment did not alter the fate of injury-induced neuro-
genesis and was demonstrated to potently increase neurogenesis. In addition, for injured ani-
mals, treatment with donepezil increases neurogenesis on the contralateral side, which may
play a role in its ability to improve recovery following TBI. We previously demonstrated that
nestin-HSV-TK mice that we generated can be used to inducibly ablate neurogenesis following
injury [3]. Since donepezil, an acetylcholine esterase inhibitor, acts on cholinergic neurons and
enhances neurogenesis, we took advantage of nestin-HSV-TK transgenic mice to inhibit neuro-
genesis and investigate whether donepezil-mediated improvement in spatial learning ability
and memory was due to enhancing neurogenesis. The nestin-HSV-TK transgenic mice were
fed with normal or valganciclovir chow starting immediately after surgery for four weeks to in-
hibit neurogenesis (Fig. 3A and B). After feeding mice valganciclovir for four weeks, CldU-la-
beled cells in the dentate gyrus were rarely found in each experimental group compared to the
ones fed normal chow (Fig. 3C). Hence, neurogenesis induced by donepezil injections and CCI
was inhibited efficiently by administering valganciclovir to nestin-HSV-TK mice.
The pro-cognitive effects of donepezil occur independently from injury-
induced neurogenesis.
We efficiently inhibited neurogenesis in donepezil-treated nestin-HSV-TK mice given val-
ganciclovir chow immediately after surgery until behavioral experiments were finished
(Fig. 4A). The hidden platform version of the Morris water maze was next performed to reveal
the role of inhibiting neurogenesis in spatial learning ability and memory in donepezil-treated
and injured animals. Again, the velocity was slower in the injured mice that were fed with val-
ganciclovir chow compared to other groups (Fig. 4B). However, the swimming speed was not
comparable to controls after donepezil was given (Fig. 4B). Following treatment with donepe-
zil, sham-operated mice performed similarly in learning to locate the platform whether
Donepezil and Neurogenesis-Dependent Recovery after TBI
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Fig 2. Donepezil treatment improved spatial learning andmemory in injured mice. (A) As depicted in
the scheme, sham- and injured mice received either vehicle or donepezil for two weeks. Four weeks after
surgery, mice were habituated for the Morris water maze. Mice were trained to find the platform for 11
Donepezil and Neurogenesis-Dependent Recovery after TBI
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neurogenesis was intact or not (Fig. 4C). Consistent with our previous study, injured mice
without neurogenesis were impaired in their ability to find the hidden platform when com-
pared to the other three groups (Fig. 4C). However, when injured mice that also had neurogen-
esis ablated were treated with donepezil, they performed in a comparable manner to sham-
injured mice (Fig. 4C).
consecutive days and a probe test was performed at day 12. (B) Swimming speed of injured mice was slower
than the other groups if no treatment was given. Donepezil treatment reversed the motor deficit in swimming.
(C) Because of deficit in swimming speed, the moving distance to finding the platform was used as an
indicator of learning ability of a novel task. Consistent with our previous study, injured mice without treatment
took the longest distance in finding the platform. However, injured mice took shorter paths after donepezil
was given. (D) Time mice spent in the target quadrant versus the summation in all other quadrants was used
as an indication of memory ability. Mice in all groups remembered the location of the platform, however,
injured mice without any treatment spent less time in the target quadrant while the rest spent more time in the
target area. Two-way ANOVA with Fisher’s LSDmultiple comparisons test was used in B and C. One-way
ANOVA with Fisher’s LSDmultiple comparisons was used in D. * p<0.05, Sham: sham-injured, CCI:
controlled cortical injury, Veh: vehicle, Don: donepezil. Number of mice used was 9 (Sham, Veh), 11 (Sham,
Don) 14 (CCI, Veh), 11 (CCI, Don).
doi:10.1371/journal.pone.0118793.g002
Fig 3. Valganciclovir chow inhibited neurogenesis in nestin-HSV-TKmice. (A and B) The representative
section demonstrates that rare CldU/NeuN double-labeled cells (arrow) were observed in the dentate gyrus
after mice were fed with valganciclovir chow for 4 consecutive weeks (40x). (C) Quantification of CldU-
labeled cells in the dentate gyrus of nestin-HSV-TK mice demonstrated that neurogenesis was efficiently
inhibited in all the experimental groups. One-way ANOVA with Fisher’s LSDmultiple comparisons was used
in C, * p<0.05, ** p<0.01, ***p<0.001, **** p<0.0001. Sham: sham-injured, CCI: controlled cortical
injury, Veh: vehicle, Don: donepezil. Nor: normal chow, Valgan: valganciclovir. Number of mice used was 4
(Sham, Veh, Nor), 5 (Sham, Veh, Valgan) 6 (Sham, Don, Nor), 5 (Sham, Don, Valgan), 3 (CCI, Veh, Nor), 3
(CCI, Veh, Valgan), 4 (CCI, Don, Nor), and 5 (CCI, Don, Valgan). Scale bar in B is 50μm.
doi:10.1371/journal.pone.0118793.g003
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Fig 4. The effect of donepezil in spatial learning andmemory in injuredmice is independent from
neurogenesis. (A) As depicted in the scheme, sham- and injured mice received either vehicle or donepezil
for two weeks. Four weeks after surgery, mice were habituated for the Morris water maze. Mice were trained
to find the platform for 11 consecutive days and a probe test was performed at day 12 Mice were fed with
Donepezil and Neurogenesis-Dependent Recovery after TBI
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Inhibition of neurogenesis in sham-operated mice did not affect the time that mice spent in
the target quadrant during the probe test regardless of donepezil treatment (Fig. 4D). As ex-
pected, vehicle-treated injured mice with inhibition of neurogenesis spent significantly less
time in the target quadrant. However, donepezil treatment reversed this deficit (Fig. 4D).
Therefore, although donepezil is a potent inducer of hippocampal neurogenesis, its pro-cogni-
tive effects seen following injury appear to occur independently of these neurogenic properties.
Discussion
In this study, we investigated whether donepezil, an FDA-approved drug used to treat Alzhei-
mer disease, contributes to pro-cognitive recovery in a neurogenic-specific way following trau-
matic brain injury. By quantifying dividing cells labeled by CldU in the dentate gyrus, a
significant increase of newborn neurons was observed in sham-operated mice treated with
donepezil, a result that was also seen following injury on the contralateral side. To further test
the effect of donepezil in cognition, the hidden platform version of the Morris water maze was
performed. Consistent with previous studies, the moving distance was longer in injured vehi-
cle-treated mice for locating the platform with the surrounding visible cues during the training
period. Although injured mice ultimately learned the task, they did not remember as well as
other groups as revealed in the probe test. Interestingly, the deficits in learning and memory
were rescued by treatment with donepezil. Furthermore, these rescued deficits were maintained
even when neurogenesis was inhibited using previously validated nestin-HSV-TK mice. There-
fore, it appears that donepezil improves recovery in spatial learning and memory in injured
mice through a neurogenesis-independent mechanism.
Donepezil is an acetylcholinesterase inhibitor that extends the effect of acetylcholine on
neurons. Although several studies suggest that donepezil enhances neurogenesis in adult ro-
dents and improves cognition in aged rats [5–7,9,10], the mechanisms underlying these obser-
vations remain unknown. Consistent with previous studies, a significant increase in newborn
neurons was noted in donepezil-treated sham-operated mice and the level of enhancement in
neurogenesis was close to that observed in injured mice. Enhanced neurogenesis is known to
improve the function of several hippocampal-based behavioral tasks [7,11–13]. Here, we ob-
served that donepezil rescued the effects of inhibiting neurogenesis following TBI. Further-
more, inhibition of neurogenesis in injured mice did not affect the pro-cognitive effects
of donepezil.
Several studies have concluded that CCI affects motor function as indicated in swimming
speed [14–17] and here, donepezil treatment resulted in a significant increase in swimming
speed in injured mice (Fig. 2D). This suggests that one of the beneficial effects of donepezil on
injured mice might be through improvement in motor activity. A recent study using donepezil
to treat rats after CCI described an opposite observation [18]. However, in that study, motor
valganciclovir chow immediately after surgery until the end of all experiments. (B) Swimming speed in injured
mice without neurogenesis and treatment was slower than controls. Donepezil treatment was able to
overcome the impairment even in the absence of neurogenesis. (C) Consistent with previous observations, in
the absence of neurogenesis the injured mice took the longest path to locate the hidden platform if no
treatment was given. However, the performance improved after injured mice were treated with donepezil
even while neurogenesis was inhibited. (D) Injured mice without neurogenesis and donepezil treatment spent
significantly less time in the target zone when compared with the summation of time spent in other zones
(open blue bars). However, treatment with donepezil reversed this deficit (open red bars). Two-way ANOVA
with Fisher’s LSD post-hoc analysis was used in A and B. One-way ANOVA with Fisher’s LSD analysis was
used in C. * p<0.05, **** p<0.001. Sham: sham-injured, CCI: controlled cortical injury, Veh: vehicle, Don:
donepezil. Nor: normal chow, Valgan: valganciclovir. Number of mice used was 10 (Sham, Veh, Valgan), 12
(Sham, Don, Valgan), 11 (CCI, Veh, Valgan), and 10 (CCI, Don, Valgan).
doi:10.1371/journal.pone.0118793.g004
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function was tested with beam balance and beam walk five days after injury. No motor tasks
were performed at similar time points as the present study, so it remains unknown if similar
improvement in motor activity might be observed over time in injured rats with donepezil
treatment. In the present study, we presented the learning data from the Morris water maze as
moving distance rather than latency time in order to control for differences in swimming speed
and therefore demonstrate that its effects on learning and memory are independent of its ef-
fects on motor function.
The lack of more obvious performance differences in the Morris water maze in our study
might be due to overtraining. Mice were trained for three trials a day on eleven consecutive
days intentionally to emphasize deficits in learning in injured mice. However, this might con-
tribute to a lack of difference in performance between vehicle- and donepezil-treated sham-op-
erated mice. Previous work demonstrated that administration of donepezil for four weeks in
mice resulted in an increase in neurogenesis and insulin-like growth factor 1 (IGF-1) in the
hippocampus and improved spatial learning and memory [7]. It was not clear whether the im-
provement of cognitive function was from an increase of IGF-1, neurogenesis, or both in that
study. Two-week treatment with donepezil in sham-operated mice in our study was sufficient
to enhance neurogenesis, but not beneficial in improving spatial learning and memory revealed
by the Morris water maze. It would be interesting to test if two-week treatment with donepezil
induces IGF-1 in the hippocampus since IGF-1 has been suggested as a beneficial factor in im-
proving cognitive function [19,20].
As expected, injured mice suffered deficits in learning a new skill, which persisted as im-
paired memory when learned without any treatment with donepezil. Interestingly, treatment
with donepezil improved the performance of injured animals to the level of sham-operated
controls. Although it is an acetylcholinesterase inhibitor that strengthens the activities of the
cholinergic system, it is not yet known how cholinergic neurons contribute to recovery from
TBI. One possible mechanism investigated in this study is injury-induced neurogenesis. The
lack of neurogenesis in nestin-HSV-TK transgenic mice did not result in deficits in spatial
learning and memory in donepezil-treated injured mice. This suggests that the mechanism un-
derlying donepezil-mediated recovery in spatial learning and memory in injured mice is not
through hippocampal neurogenesis.
Although donepezil induced a significant increase in neurogenesis in sham-injured mice,
this effect was more modest in donepezil-treated injured mice. It is possible that injury activat-
ed all available neural progenitors to develop into newborn neurons as indicated in our previ-
ous study [2], and that this occurs via a similar mechanism by which donepezil enhances
neurogenesis. In addition, although the mechanisms may be totally unrelated, the degree to
which existing progenitors can be stimulated might be limited by whether this occurs second-
ary to injury or pharmacologic stimulus. If this is the case, it suggests that donepezil is not able
to activate the quiescent type I neural stem cells.
Unlike what was seen in injured mice, there was no significant effect observed in learning
and memory ability in the water maze task in sham-operated mice treated with donepezil.
However, donepezil-treated sham-operated mice without neurogenesis performed better in the
probe task compared to the comparative control group with neurogenesis. Although a recent
study demonstrated that neurogenesis interferes with existing remote memory [21], it does not
provide an explanation for our observations since neurogenesis was inhibited before the begin-
ning of the training and probe tasks. Overall, these data suggest that in sham-operated mice the
donepezil-induced neurogenesis might interfere with newly formed memories, although fur-
ther study is required to confirm this observation.
This study demonstrates that donepezil improves recovery of spatial learning and memory
in injured mice and that this effect occurs largely independent from injury-induced
Donepezil and Neurogenesis-Dependent Recovery after TBI
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neurogenesis. This suggests that enhancing cognition following TBI occurs through new neu-
ron-dependent and independent mechanisms and provides a potential route for improving
cognitive recovery in brain-injured patients.
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